Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Burnett

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Ecology and Evolution|August 15, 2024
Bimodal spore release heights in the water column enhance local retention and population connectivity of bull kelp, <i>Nereocystis luetkeana</i>Nicholas P Burnett, Aurora M Ricart, Tallulah Winquist, et al.
Advances in Therapy|September 17, 2010
Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the kneeRobert M Levy, Alexander Khokhlov, Sergey Kopenkin, et al.
Nanomedicine (London, England)|December 24, 2019
Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapyHongwei Chen, Xin Luan, Hayley J Paholak, et al.
Neuropharmacology|August 1, 1995
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylateD D Schoepp, B G Johnson, C R Salhoff, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
American Journal of Otolaryngology|June 16, 2019
Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiationBhaswanth Dhanireddy, Nicolas P Burnett, Sreeja Sanampudi, et al.
Breast Cancer Research and Treatment|April 3, 2015
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancerSarah J Conley, Trenton L Baker, Joseph P Burnett, et al.
Schizophrenia Research and Treatment|September 1, 2012
Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot StudyJ Edwards, J Cocks, P Burnett, et al.
World Journal of Gastroenterology|September 11, 2014
Bovine immunoglobulin protein isolates for the nutritional management of enteropathyBryon W Petschow, Anthony T Blikslager, Eric M Weaver, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Ecology and Evolution|August 15, 2024
Bimodal spore release heights in the water column enhance local retention and population connectivity of bull kelp, <i>Nereocystis luetkeana</i>Nicholas P Burnett, Aurora M Ricart, Tallulah Winquist, et al.
Advances in Therapy|September 17, 2010
Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the kneeRobert M Levy, Alexander Khokhlov, Sergey Kopenkin, et al.
Nanomedicine (London, England)|December 24, 2019
Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapyHongwei Chen, Xin Luan, Hayley J Paholak, et al.
Neuropharmacology|August 1, 1995
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylateD D Schoepp, B G Johnson, C R Salhoff, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
American Journal of Otolaryngology|June 16, 2019
Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiationBhaswanth Dhanireddy, Nicolas P Burnett, Sreeja Sanampudi, et al.
Breast Cancer Research and Treatment|April 3, 2015
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancerSarah J Conley, Trenton L Baker, Joseph P Burnett, et al.
Schizophrenia Research and Treatment|September 1, 2012
Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot StudyJ Edwards, J Cocks, P Burnett, et al.
World Journal of Gastroenterology|September 11, 2014
Bovine immunoglobulin protein isolates for the nutritional management of enteropathyBryon W Petschow, Anthony T Blikslager, Eric M Weaver, et al.
Pageof 12